|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 356.40 CHF | -0.64% |
|
+1.63% | +8.59% |
| 12:25am | Roche's Investigational Drug Trial Shows Reduction in Progression of Multiple Sclerosis | MT |
| Feb. 07 | Roche's multiple sclerosis drug fenebrutinib meets goal in late-stage trial | RE |
Trading Ideas
Search
No results for this search
Filters
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Trading Ideas
Select your edition
All financial news and data tailored to specific country editions


















